267 related articles for article (PubMed ID: 1347643)
1. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
Goyette MC; Cho K; Fasching CL; Levy DB; Kinzler KW; Paraskeva C; Vogelstein B; Stanbridge EJ
Mol Cell Biol; 1992 Mar; 12(3):1387-95. PubMed ID: 1347643
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18.
Tanaka K; Oshimura M; Kikuchi R; Seki M; Hayashi T; Miyaki M
Nature; 1991 Jan; 349(6307):340-2. PubMed ID: 1670965
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
[TBL] [Abstract][Full Text] [Related]
5. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
[TBL] [Abstract][Full Text] [Related]
6. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
8. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer.
Khine K; Smith DR; Goh HS
Cancer; 1994 Jan; 73(1):28-35. PubMed ID: 8275434
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer.
Satoh H; Lamb PW; Dong JT; Everitt J; Boreiko C; Oshimura M; Barrett JC
Mol Carcinog; 1993; 7(3):157-64. PubMed ID: 8098218
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
[TBL] [Abstract][Full Text] [Related]
11. Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18.
Yamada H; Sasaki M; Honda T; Wake N; Boyd J; Oshimura M; Barrett JC
Genes Chromosomes Cancer; 1995 May; 13(1):18-24. PubMed ID: 7541639
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
[TBL] [Abstract][Full Text] [Related]
13. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
14. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and K-ras gene mutations in gastric cancer.
Ranzani GN; Renault B; Pellegata NS; Fattorini P; Magni E; Bacci F; Amadori D
Hum Genet; 1993 Oct; 92(3):244-9. PubMed ID: 8406432
[TBL] [Abstract][Full Text] [Related]
16. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
17. Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080.
Anderson MJ; Casey G; Fasching CL; Stanbridge EJ
Genes Chromosomes Cancer; 1994 Apr; 9(4):266-81. PubMed ID: 7519049
[TBL] [Abstract][Full Text] [Related]
18. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenicity and induction of senescence on human endometrial carcinoma cell lines by transfer of normal human chromosomes.
Yamada H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1443-54. PubMed ID: 7705753
[TBL] [Abstract][Full Text] [Related]
20. [Accumulation of genetic alterations during human tumor progression].
Yokota J; Ookawa K
Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
